
    
      Comparing the frequency of new Gd enhancing lesions in a group of patients presenting a
      residual MRI activity during the last four months of the six month standard dose (8MIU)
      Betaferon treatment randomized to continue the standard dose or to increase the dose to 12
      MIU Betaferon
    
  